FDA Clinical Process and U.S. Regulatory Submissions
Informa Connect’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs. Connect with key stakeholders and propel curative progress, orphan product success and patient advocacy.
Bethany Hills was a speaker for the "FDA Clinical Process and U.S. Regulatory Submissions" session.
Additional speakers for the session:
Leonide Saad - CEO, Alkeus Pharmaceuticals, Inc.
Mark A. Rutter - Senior Director, Global Regulatory Policy, Biogen